Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk

Epidemiologic and laboratory studies support a role for the vitamin D endocrine system in ovarian carcinogenesis. The association of ovarian cancer risk with polymorphisms in the vitamin D receptor ( VDR ) gene, including rs10735810 ( Fok I), rs11568820 ( Cdx -2), rs1544410 ( Bsm I), rs7975232 ( Apa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2007-12, Vol.16 (12), p.2566-2571
Hauptverfasser: LURIE, Galina, WILKENS, Lynne R, THOMPSON, Pamela J, MCDUFFIE, Katharine E, CARNEY, Michael E, TERADA, Keith Y, GOODMAN, Marc T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2571
container_issue 12
container_start_page 2566
container_title Cancer epidemiology, biomarkers & prevention
container_volume 16
creator LURIE, Galina
WILKENS, Lynne R
THOMPSON, Pamela J
MCDUFFIE, Katharine E
CARNEY, Michael E
TERADA, Keith Y
GOODMAN, Marc T
description Epidemiologic and laboratory studies support a role for the vitamin D endocrine system in ovarian carcinogenesis. The association of ovarian cancer risk with polymorphisms in the vitamin D receptor ( VDR ) gene, including rs10735810 ( Fok I), rs11568820 ( Cdx -2), rs1544410 ( Bsm I), rs7975232 ( Apa I), rs731236 ( Taq I), and Bsm I- Apa I- Taq I combined genotypes, was examined among 313 women with epithelial ovarian carcinoma and 574 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. The associations of VDR polymorphisms with risk were generally inconsistent across ethnic groups. Among Caucasian women (72 cases, 148 controls), heterozygous and homozygous Apa I A allele carriers were at increased ovarian carcinoma risk compared with homozygous carriers of the Apa I a allele (OR 2.8, 95% CI 1.2-7.0 and OR 3.4, 95% CI 1.3-9.1; P trend = 0.02). Caucasian heterozygous carriers of Fok I f allele were also at increased risk of ovarian carcinoma compared with homozygous carriers of the common allele (OR 2.5, 95% CI 1.3-4.8; P trend = 0.04). Among Japanese women (94 cases, 173 controls), ovarian cancer risk was significantly decreased (OR 0.5, 95% CI 0.3-0.9) among Cdx-2 A allele heterozygotes compared with homozygote G allele carriers ( P trend = 0.03). Compared with the bbaaTT Bsm I- Apa I- Taq I genotype, bbaATT and BBAAtt genotypes were associated with increased ovarian cancer risk in Caucasian women (OR 4.2, 95% CI 1.3-13.1 and OR 5.2, 95% CI 1.6-17.5), but not in Japanese women (OR 1.1, 95% CI 0.6-1.9 and OR 2.3, 95% CI:0.4-12.3). This investigation provides some evidence that polymorphisms in the VDR gene might influence ovarian cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2566–71)
doi_str_mv 10.1158/1055-9965.EPI-07-0753
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20727094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20727094</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-a2d0a8d4dd7bec0114539bc6a2331b1fef17ff63f31b4ee547ee751c14b533ce3</originalsourceid><addsrcrecordid>eNpF0MtKxDAUgOEgivdHULJRcFFNmp6mXco4XkCYQdRtSNNTG-3NpKP49macUSGQBL6TwE_IEWfnnEN2wRlAlOcpnE_ndxGTYYHYILscRBZJCbAZzr9mh-x5_8oYkznANtnhGctSCfkuuX22o25tR6_oAxocxt7RG-yQzvvmq-3dUFvfeqq7kk4HO9bYWN3Q2Yd2Vnd0ojuDjj5Y_3ZAtirdeDxc7_vk6Xr6OLmN7mc3d5PL-8gkLB4jHZdMZ2VSlrJAwzhPQOSFSXUsBC94hRWXVZWKKtwSREgkogRueFKAEAbFPjldvTu4_n2BflSt9QabRnfYL7yKmYwly5MAYQWN6713WKnB2Va7L8WZWiZUyzxqmUeFhIpJtUwY5o7XHyyKFsv_qXWzAE7WQHujm8qFCNb_uThkzrM0De5s5Wr7Un9ah8r85HLoUTtTK54qHqsYgv0GjZ-H2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20727094</pqid></control><display><type>article</type><title>Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk</title><source>Electronic Journals Library</source><source>MEDLINE</source><source>American Association for Cancer Research Journals</source><creator>LURIE, Galina ; WILKENS, Lynne R ; THOMPSON, Pamela J ; MCDUFFIE, Katharine E ; CARNEY, Michael E ; TERADA, Keith Y ; GOODMAN, Marc T</creator><creatorcontrib>LURIE, Galina ; WILKENS, Lynne R ; THOMPSON, Pamela J ; MCDUFFIE, Katharine E ; CARNEY, Michael E ; TERADA, Keith Y ; GOODMAN, Marc T</creatorcontrib><description>Epidemiologic and laboratory studies support a role for the vitamin D endocrine system in ovarian carcinogenesis. The association of ovarian cancer risk with polymorphisms in the vitamin D receptor ( VDR ) gene, including rs10735810 ( Fok I), rs11568820 ( Cdx -2), rs1544410 ( Bsm I), rs7975232 ( Apa I), rs731236 ( Taq I), and Bsm I- Apa I- Taq I combined genotypes, was examined among 313 women with epithelial ovarian carcinoma and 574 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. The associations of VDR polymorphisms with risk were generally inconsistent across ethnic groups. Among Caucasian women (72 cases, 148 controls), heterozygous and homozygous Apa I A allele carriers were at increased ovarian carcinoma risk compared with homozygous carriers of the Apa I a allele (OR 2.8, 95% CI 1.2-7.0 and OR 3.4, 95% CI 1.3-9.1; P trend = 0.02). Caucasian heterozygous carriers of Fok I f allele were also at increased risk of ovarian carcinoma compared with homozygous carriers of the common allele (OR 2.5, 95% CI 1.3-4.8; P trend = 0.04). Among Japanese women (94 cases, 173 controls), ovarian cancer risk was significantly decreased (OR 0.5, 95% CI 0.3-0.9) among Cdx-2 A allele heterozygotes compared with homozygote G allele carriers ( P trend = 0.03). Compared with the bbaaTT Bsm I- Apa I- Taq I genotype, bbaATT and BBAAtt genotypes were associated with increased ovarian cancer risk in Caucasian women (OR 4.2, 95% CI 1.3-13.1 and OR 5.2, 95% CI 1.6-17.5), but not in Japanese women (OR 1.1, 95% CI 0.6-1.9 and OR 2.3, 95% CI:0.4-12.3). This investigation provides some evidence that polymorphisms in the VDR gene might influence ovarian cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2566–71)</description><identifier>ISSN: 1055-9965</identifier><identifier>EISSN: 1538-7755</identifier><identifier>DOI: 10.1158/1055-9965.EPI-07-0753</identifier><identifier>PMID: 18086759</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Case-Control Studies ; case-control study ; Continental Population Groups ; epithelial ovarian cancer ; Female ; Female genital diseases ; genetic epidemiology ; Genetic Predisposition to Disease - ethnology ; Genotype ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Middle Aged ; Neoplasms, Glandular and Epithelial - ethnology ; Neoplasms, Glandular and Epithelial - genetics ; Ovarian Neoplasms - ethnology ; Ovarian Neoplasms - genetics ; Polymerase Chain Reaction ; Polymorphism, Genetic ; Receptors, Calcitriol - genetics ; Risk Factors ; single-nucleotide polymorphisms ; Tumors ; VDR ; vitamin D receptor gene</subject><ispartof>Cancer epidemiology, biomarkers &amp; prevention, 2007-12, Vol.16 (12), p.2566-2571</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-a2d0a8d4dd7bec0114539bc6a2331b1fef17ff63f31b4ee547ee751c14b533ce3</citedby><cites>FETCH-LOGICAL-c402t-a2d0a8d4dd7bec0114539bc6a2331b1fef17ff63f31b4ee547ee751c14b533ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20009866$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18086759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LURIE, Galina</creatorcontrib><creatorcontrib>WILKENS, Lynne R</creatorcontrib><creatorcontrib>THOMPSON, Pamela J</creatorcontrib><creatorcontrib>MCDUFFIE, Katharine E</creatorcontrib><creatorcontrib>CARNEY, Michael E</creatorcontrib><creatorcontrib>TERADA, Keith Y</creatorcontrib><creatorcontrib>GOODMAN, Marc T</creatorcontrib><title>Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk</title><title>Cancer epidemiology, biomarkers &amp; prevention</title><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><description>Epidemiologic and laboratory studies support a role for the vitamin D endocrine system in ovarian carcinogenesis. The association of ovarian cancer risk with polymorphisms in the vitamin D receptor ( VDR ) gene, including rs10735810 ( Fok I), rs11568820 ( Cdx -2), rs1544410 ( Bsm I), rs7975232 ( Apa I), rs731236 ( Taq I), and Bsm I- Apa I- Taq I combined genotypes, was examined among 313 women with epithelial ovarian carcinoma and 574 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. The associations of VDR polymorphisms with risk were generally inconsistent across ethnic groups. Among Caucasian women (72 cases, 148 controls), heterozygous and homozygous Apa I A allele carriers were at increased ovarian carcinoma risk compared with homozygous carriers of the Apa I a allele (OR 2.8, 95% CI 1.2-7.0 and OR 3.4, 95% CI 1.3-9.1; P trend = 0.02). Caucasian heterozygous carriers of Fok I f allele were also at increased risk of ovarian carcinoma compared with homozygous carriers of the common allele (OR 2.5, 95% CI 1.3-4.8; P trend = 0.04). Among Japanese women (94 cases, 173 controls), ovarian cancer risk was significantly decreased (OR 0.5, 95% CI 0.3-0.9) among Cdx-2 A allele heterozygotes compared with homozygote G allele carriers ( P trend = 0.03). Compared with the bbaaTT Bsm I- Apa I- Taq I genotype, bbaATT and BBAAtt genotypes were associated with increased ovarian cancer risk in Caucasian women (OR 4.2, 95% CI 1.3-13.1 and OR 5.2, 95% CI 1.6-17.5), but not in Japanese women (OR 1.1, 95% CI 0.6-1.9 and OR 2.3, 95% CI:0.4-12.3). This investigation provides some evidence that polymorphisms in the VDR gene might influence ovarian cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2566–71)</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>case-control study</subject><subject>Continental Population Groups</subject><subject>epithelial ovarian cancer</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>genetic epidemiology</subject><subject>Genetic Predisposition to Disease - ethnology</subject><subject>Genotype</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasms, Glandular and Epithelial - ethnology</subject><subject>Neoplasms, Glandular and Epithelial - genetics</subject><subject>Ovarian Neoplasms - ethnology</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Genetic</subject><subject>Receptors, Calcitriol - genetics</subject><subject>Risk Factors</subject><subject>single-nucleotide polymorphisms</subject><subject>Tumors</subject><subject>VDR</subject><subject>vitamin D receptor gene</subject><issn>1055-9965</issn><issn>1538-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0MtKxDAUgOEgivdHULJRcFFNmp6mXco4XkCYQdRtSNNTG-3NpKP49macUSGQBL6TwE_IEWfnnEN2wRlAlOcpnE_ndxGTYYHYILscRBZJCbAZzr9mh-x5_8oYkznANtnhGctSCfkuuX22o25tR6_oAxocxt7RG-yQzvvmq-3dUFvfeqq7kk4HO9bYWN3Q2Yd2Vnd0ojuDjj5Y_3ZAtirdeDxc7_vk6Xr6OLmN7mc3d5PL-8gkLB4jHZdMZ2VSlrJAwzhPQOSFSXUsBC94hRWXVZWKKtwSREgkogRueFKAEAbFPjldvTu4_n2BflSt9QabRnfYL7yKmYwly5MAYQWN6713WKnB2Va7L8WZWiZUyzxqmUeFhIpJtUwY5o7XHyyKFsv_qXWzAE7WQHujm8qFCNb_uThkzrM0De5s5Wr7Un9ah8r85HLoUTtTK54qHqsYgv0GjZ-H2A</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>LURIE, Galina</creator><creator>WILKENS, Lynne R</creator><creator>THOMPSON, Pamela J</creator><creator>MCDUFFIE, Katharine E</creator><creator>CARNEY, Michael E</creator><creator>TERADA, Keith Y</creator><creator>GOODMAN, Marc T</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20071201</creationdate><title>Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk</title><author>LURIE, Galina ; WILKENS, Lynne R ; THOMPSON, Pamela J ; MCDUFFIE, Katharine E ; CARNEY, Michael E ; TERADA, Keith Y ; GOODMAN, Marc T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-a2d0a8d4dd7bec0114539bc6a2331b1fef17ff63f31b4ee547ee751c14b533ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>case-control study</topic><topic>Continental Population Groups</topic><topic>epithelial ovarian cancer</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>genetic epidemiology</topic><topic>Genetic Predisposition to Disease - ethnology</topic><topic>Genotype</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasms, Glandular and Epithelial - ethnology</topic><topic>Neoplasms, Glandular and Epithelial - genetics</topic><topic>Ovarian Neoplasms - ethnology</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Genetic</topic><topic>Receptors, Calcitriol - genetics</topic><topic>Risk Factors</topic><topic>single-nucleotide polymorphisms</topic><topic>Tumors</topic><topic>VDR</topic><topic>vitamin D receptor gene</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LURIE, Galina</creatorcontrib><creatorcontrib>WILKENS, Lynne R</creatorcontrib><creatorcontrib>THOMPSON, Pamela J</creatorcontrib><creatorcontrib>MCDUFFIE, Katharine E</creatorcontrib><creatorcontrib>CARNEY, Michael E</creatorcontrib><creatorcontrib>TERADA, Keith Y</creatorcontrib><creatorcontrib>GOODMAN, Marc T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LURIE, Galina</au><au>WILKENS, Lynne R</au><au>THOMPSON, Pamela J</au><au>MCDUFFIE, Katharine E</au><au>CARNEY, Michael E</au><au>TERADA, Keith Y</au><au>GOODMAN, Marc T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk</atitle><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>16</volume><issue>12</issue><spage>2566</spage><epage>2571</epage><pages>2566-2571</pages><issn>1055-9965</issn><eissn>1538-7755</eissn><abstract>Epidemiologic and laboratory studies support a role for the vitamin D endocrine system in ovarian carcinogenesis. The association of ovarian cancer risk with polymorphisms in the vitamin D receptor ( VDR ) gene, including rs10735810 ( Fok I), rs11568820 ( Cdx -2), rs1544410 ( Bsm I), rs7975232 ( Apa I), rs731236 ( Taq I), and Bsm I- Apa I- Taq I combined genotypes, was examined among 313 women with epithelial ovarian carcinoma and 574 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. The associations of VDR polymorphisms with risk were generally inconsistent across ethnic groups. Among Caucasian women (72 cases, 148 controls), heterozygous and homozygous Apa I A allele carriers were at increased ovarian carcinoma risk compared with homozygous carriers of the Apa I a allele (OR 2.8, 95% CI 1.2-7.0 and OR 3.4, 95% CI 1.3-9.1; P trend = 0.02). Caucasian heterozygous carriers of Fok I f allele were also at increased risk of ovarian carcinoma compared with homozygous carriers of the common allele (OR 2.5, 95% CI 1.3-4.8; P trend = 0.04). Among Japanese women (94 cases, 173 controls), ovarian cancer risk was significantly decreased (OR 0.5, 95% CI 0.3-0.9) among Cdx-2 A allele heterozygotes compared with homozygote G allele carriers ( P trend = 0.03). Compared with the bbaaTT Bsm I- Apa I- Taq I genotype, bbaATT and BBAAtt genotypes were associated with increased ovarian cancer risk in Caucasian women (OR 4.2, 95% CI 1.3-13.1 and OR 5.2, 95% CI 1.6-17.5), but not in Japanese women (OR 1.1, 95% CI 0.6-1.9 and OR 2.3, 95% CI:0.4-12.3). This investigation provides some evidence that polymorphisms in the VDR gene might influence ovarian cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2566–71)</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>18086759</pmid><doi>10.1158/1055-9965.EPI-07-0753</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1055-9965
ispartof Cancer epidemiology, biomarkers & prevention, 2007-12, Vol.16 (12), p.2566-2571
issn 1055-9965
1538-7755
language eng
recordid cdi_proquest_miscellaneous_20727094
source Electronic Journals Library; MEDLINE; American Association for Cancer Research Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Case-Control Studies
case-control study
Continental Population Groups
epithelial ovarian cancer
Female
Female genital diseases
genetic epidemiology
Genetic Predisposition to Disease - ethnology
Genotype
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Middle Aged
Neoplasms, Glandular and Epithelial - ethnology
Neoplasms, Glandular and Epithelial - genetics
Ovarian Neoplasms - ethnology
Ovarian Neoplasms - genetics
Polymerase Chain Reaction
Polymorphism, Genetic
Receptors, Calcitriol - genetics
Risk Factors
single-nucleotide polymorphisms
Tumors
VDR
vitamin D receptor gene
title Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A45%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20Receptor%20Gene%20Polymorphisms%20and%20Epithelial%20Ovarian%20Cancer%20Risk&rft.jtitle=Cancer%20epidemiology,%20biomarkers%20&%20prevention&rft.au=LURIE,%20Galina&rft.date=2007-12-01&rft.volume=16&rft.issue=12&rft.spage=2566&rft.epage=2571&rft.pages=2566-2571&rft.issn=1055-9965&rft.eissn=1538-7755&rft_id=info:doi/10.1158/1055-9965.EPI-07-0753&rft_dat=%3Cproquest_cross%3E20727094%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20727094&rft_id=info:pmid/18086759&rfr_iscdi=true